// App-Quantinova.ai

P969 : COMPARISON OF VENOUS THROMBOEMBOLISM INCIDENCE IN MULTIPLE MYELOMA PATIENTS RECEIVING LENALIDOMIDE-BASED REGIMENS WITH RIVAROXABAN OR ASPIRIN THROMBOPROPHYLAXIS

Researchers

Presenter

  • Yan Wang

Principal Investigators

  • Xinyu Tang

  • Wei Zheng

  • Zhenzhen Wang

  • Jie Xu

  • Xing Tan

  • Yu Tian

  • Ruirong Xu

  • Siyuan Cui

Medical Centers

  • Affiliated Hospital of Shandong University of Traditional Chinese Medicine,Jinan , Shandong,China

  • Affiliated Hospital of Shandong University of Traditional Chinese Medicine,Jinan , Shandong,China

  • Affiliate

  • Affiliated Hospital of Shandong University of Traditional Chinese Medicine,Jinan , Shandong,China

  • Shandong University of Tra

  • Affiliated Hospital of Shandong University of Traditional Chinese Medicine,Jinan , Shandong,China

  • Affiliated Hospital of Shandong University of Traditional Chinese Medicine,Jinan , Shandong,China

  • Shandong University of Traditional Chinese Medicine,Jinan , Shandong,Cina

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Oncology (ONC)

Disease

  • Venous thrombosis

  • Deep vein thrombosis

  • Pulmonary embolism

  • Multiple Myeloma

Biomarkers

  • N/A

Drug/Treatment

  • Lenalidomide

  • rivaroxaban

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved